litlas
ログインアカウント作成

Gary J. Kelloff

1966–2023 年に発表

97
論文数
19,466
被引用数
81
h 指数
97
i10 指数

被引用数

Gary J. Kelloff の年別被引用数1966 年: 被引用 2 件1967 年: 被引用 2 件1968 年: 被引用 1 件1969 年: 被引用 2 件1970 年: 被引用 2 件1971 年: 被引用 15 件1972 年: 被引用 18 件1973 年: 被引用 10 件1974 年: 被引用 12 件1975 年: 被引用 2 件1976 年: 被引用 3 件1977 年: 被引用 1 件1978 年: 被引用 2 件1979 年: 被引用 2 件1980 年: 被引用 1 件1982 年: 被引用 3 件1983 年: 被引用 2 件1984 年: 被引用 2 件1986 年: 被引用 1 件1990 年: 被引用 2 件1991 年: 被引用 16 件1992 年: 被引用 22 件1993 年: 被引用 23 件1994 年: 被引用 47 件1995 年: 被引用 42 件1996 年: 被引用 91 件1997 年: 被引用 69 件1998 年: 被引用 116 件1999 年: 被引用 180 件2000 年: 被引用 241 件2001 年: 被引用 294 件2002 年: 被引用 357 件2003 年: 被引用 322 件2004 年: 被引用 373 件2005 年: 被引用 298 件2006 年: 被引用 283 件2007 年: 被引用 239 件2008 年: 被引用 194 件2009 年: 被引用 179 件2010 年: 被引用 147 件2011 年: 被引用 151 件2012 年: 被引用 118 件2013 年: 被引用 122 件2014 年: 被引用 109 件2015 年: 被引用 117 件2016 年: 被引用 91 件2017 年: 被引用 89 件2018 年: 被引用 95 件2019 年: 被引用 248 件2020 年: 被引用 240 件2021 年: 被引用 196 件2022 年: 被引用 143 件2023 年: 被引用 105 件2024 年: 被引用 144 件2025 年: 被引用 76 件2026 年: 被引用 3 件1981 年は被引用が無いため表示していません1985 年は被引用が無いため表示していません1987〜1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,408 件、この内訳の 39%イギリス: 引用元論文 406 件、この内訳の 6.6%中国: 引用元論文 309 件、この内訳の 5%イタリア: 引用元論文 267 件、この内訳の 4.3%ドイツ: 引用元論文 237 件、この内訳の 3.9%インド: 引用元論文 230 件、この内訳の 3.7%日本: 引用元論文 209 件、この内訳の 3.4%カナダ: 引用元論文 204 件、この内訳の 3.3%フランス: 引用元論文 186 件、この内訳の 3%韓国: 引用元論文 147 件、この内訳の 2.4%オランダ: 引用元論文 144 件、この内訳の 2.3%スペイン: 引用元論文 115 件、この内訳の 1.9%
0%39%その他 21.2%

機関

分野

  • Medicine53.6%
  • Biochemistry, Genetics and Molecular Biology31.4%
  • Agricultural and Biological Sciences3.4%
  • Pharmacology, Toxicology and Pharmaceutics1.9%
  • Immunology and Microbiology1.7%
  • Chemistry1.5%
  • その他6.5%

トピック

  • Inflammatory mediators and NSAID effects5.3%
  • Genomics, phytochemicals, and oxidative stress3.1%
  • Curcumin's Biomedical Applications2.8%
  • Estrogen and related hormone effects2.8%
  • Cancer Genomics and Diagnostics1.9%
  • Cancer, Lipids, and Metabolism1.8%
  • その他82.3%

共著者

全論文

検索で開く
  1. Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia

    著者: Donald A. Berry, Shouhao Zhou, Howard R. Higley, Lata Mukundan, Shuangshuang Fu, Gregory H. Reaman, Brent L. Wood, Gary J. Kelloff, J. Milburn Jessup, Jerald P. Radich - JAMA Oncology 2017 被引用: 568

  2. Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration

    著者: Kenneth C. Anderson, Daniel Auclair, Stacey J. Adam, Amit Agarwal, Melissa Anderson, Hervé Avet‐Loiseau, Mark Bustoros, Jessica R. Chapman, Dana E. Connors, Ajeeta B. Dash, Alessandra Di Bacco, Du Ling, Thierry Façon, Juan Flores‐Montero, Francesca Gay, Irene M. Ghobrial, Nicole Gormley, Ira Gupta, Howard R. Higley, Jens Hillengaß, Bindu Kanapuru, Dickran Kazandjian, Gary J. Kelloff, Ilan R. Kirsch, Brandon E. Kremer, Ola Landgren, Elizabeth D. Lightbody, Oliver Lomas, Sagar Lonial, María‐Victoria Mateos, Rocío Montes de, Lata Mukundan, Nikhil C. Munshi, Elizabeth O’Donnell, Alberto Órfão, Bruno Paiva, Reshma Patel, Trevor J. Pugh, Karthik Ramasamy, Jill Ray, Mikhail Roshal, Jeremy A. Ross, Caroline C. Sigman, Katie Thoren, Suzanne Trudel, Gary A. Ulaner, Nancy Valente, Brendan M. Weiss, Elena Zamagni, Shaji Kumar - Clinical Cancer Research 2021 被引用: 64

  3. Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development

    著者: Gary J. Kelloff, John M. Hoffman, Bruce E. Johnson, Howard I. Scher, Barry A. Siegel, Edward Y. Cheng, Bruce D. Cheson, Joyce O’Shaughnessy, Kathryn Z. Guyton, David A. Mankoff, Lalitha Shankar, Steven M. Larson, Caroline C. Sigman, Richard L. Schilsky, Daniel C. Sullivan - Clinical Cancer Research 2005 被引用: 669

  4. Challenges to Using Big Data in Cancer

    著者: Shawn M. Sweeney, Hisham K. Hamadeh, Natalie Abrams, Stacey J. Adam, Sara Brenner, Dana E. Connors, Gerard J. Davis, Louis D. Fiore, Susan H. Gawel, Robert L. Grossman, Sean E. Hanlon, Karl Hsu, Gary J. Kelloff, Ilan R. Kirsch, Bill Louv, Deven McGraw, Frank Meng, Daniel Milgram, Robert S. Miller, Emily Morgan, Lata Mukundan, Thomas O’Brien, Paul B. Robbins, Eric H. Rubin, Wendy S. Rubinstein, Liz Salmi, Teilo Schaller, George Shi, Caroline C. Sigman, Sudhir Srivastava - Cancer Research 2023 被引用: 60

  5. The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis

    著者: Gideon Steinbach, Patrick M. Lynch, Robin Phillips, Marina Wallace, Ernest T. Hawk, Gary Gordon, Naoki Wakabayashi, Brian P. Saunders, Yu Shen, Takashi Fujimura, Li-Kuo Su, Bernard Levin, LOUIS B. GODIO, Sherri Patterson, Miguel A. Rodrı́guez-Bigas, Susan L. Jester, Karen L. King, Marta Schumacher, James L. Abbruzzese, Raymond N. DuBois, Walter N. Hittelman, Stuart O. Zimmerman, Jeffrey W. Sherman, Gary J. Kelloff - New England Journal of Medicine 2000 被引用: 2,526

  6. Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial

    著者: Heiko Schöder, Mei‐Yin C. Polley, Michael V. Knopp, Nathan C. Hall, Lale Kostakoglu, Jun Zhang, Howard R. Higley, Gary J. Kelloff, Heshan Liu, Andrew D. Zelenetz, Bruce D. Cheson, Nina D. Wagner‐Johnston, Brad S. Kahl, Jonathan W. Friedberg, Eric D. Hsi, John P. Leonard, Lawrence H. Schwartz, Wyndham H. Wilson, Nancy L. Bartlett - Blood 2020 被引用: 94

  7. Considerations in the development of circulating tumor cell technology for clinical use

    著者: David Parkinson, Nicholas C. Dracopoli, Brenda Gumbs Petty, Carolyn C. Compton, Massimo Cristofanilli, Albert Deisseroth, Daniel F. Hayes, Gordon F. Kapke, Prasanna Kumar, Jerry Lee, Minetta C. Liu, Robert McCormack, Stanislaw M. Mikulski, Larry A. Nagahara, Klaus Pantel, Sonia Pearson‐White, Elizabeth A. Punnoose, Lori Roadcap, Andrew E. Schade, Howard I. Scher, Caroline C. Sigman, Gary J. Kelloff - Journal of Translational Medicine 2012 被引用: 327

  8. Cancer biomarkers: selecting the right drug for the right patient

    著者: Gary J. Kelloff, Caroline C. Sigman - Nature Reviews Drug Discovery 2012 被引用: 251

  9. Lung Master Protocol (Lung-MAP)—A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400

    著者: Roy S. Herbst, David R. Gandara, Fred R. Hirsch, Mary W. Redman, Michael LeBlanc, Philip C. Mack, Lawrence H. Schwartz, Everett E. Vokes, Suresh S. Ramalingam, Jeffrey D. Bradley, Dana B. Sparks, Yang Zhou, Crystal Miwa, Vincent A. Miller, Roman Yelensky, Yali Li, Jeff Allen, Ellen V. Sigal, David Wholley, Caroline C. Sigman, Gideon M. Blumenthal, Shakun Malik, Gary J. Kelloff, Jeffrey S. Abrams, Charles D. Blanke, Vassiliki A. Papadimitrakopoulou - Clinical Cancer Research 2015 被引用: 240

  10. Case Studies for Overcoming Challenges in Using Big Data in Cancer

    著者: Shawn M. Sweeney, Hisham K. Hamadeh, Natalie Abrams, Stacey J. Adam, Sara Brenner, Dana E. Connors, Gerard J. Davis, Louis D. Fiore, Susan H. Gawel, Robert L. Grossman, Sean E. Hanlon, Karl Hsu, Gary J. Kelloff, Ilan R. Kirsch, Bill Louv, Deven McGraw, Frank Meng, Daniel Milgram, Robert S. Miller, Emily Morgan, Lata Mukundan, Thomas O’Brien, Paul B. Robbins, Eric H. Rubin, Wendy S. Rubinstein, Liz Salmi, Teilo Schaller, George Shi, Caroline C. Sigman, Sudhir Srivastava - Cancer Research 2023 被引用: 21

  11. Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial

    著者: Frank L. Meyskens, Christine E. McLaren, Daniel Pelot, Sharon Fujikawa-Brooks, Philip M. Carpenter, Ernest T. Hawk, Gary J. Kelloff, Michael J. Lawson, Jayashri Kidao, John A. McCracken, Gregory Albers, Dennis J. Ahnen, D. Kim Turgeon, Steven Goldschmid, Peter Lance, Curt H. Hagedorn, Daniel L. Gillen, Eugene W. Gerner - Cancer Prevention Research 2008 被引用: 519

  12. State of the Science and Future Directions for Liquid Biopsies in Drug Development

    著者: Preeti Narayan, Soma Ghosh, Reena Philip, J. Carl Barrett, Robert McCormack, Justin I. Odegaard, Geoffrey R. Oxnard, Laurel J. Pracht, P. Mickey Williams, Gary J. Kelloff, Julia A. Beaver - The Oncologist 2020 被引用: 15

  13. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.

    著者: Russell F. Jacoby, Karen Seibert, Carolyn E. Cole, Gary J. Kelloff, Ronald A. Lubet - 2000 被引用: 483

  14. The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications

    著者: Kenneth C. Anderson, Daniel Auclair, Gary J. Kelloff, Caroline C. Sigman, Hervé Avet‐Loiseau, Ann T. Farrell, Nicole Gormley, Shaji Kumar, Ola Landgren, Nikhil C. Munshi, Michèle Cavo, Faith E. Davies, Alessandra Di Bacco, Jennifer S. Dickey, Steven Gutman, Howard R. Higley, Mohamad A. Hussein, J. Milburn Jessup, Ilan R. Kirsch, Richard F. Little, Robert D. Loberg, Jens G. Lohr, Lata Mukundan, James Omel, Trevor J. Pugh, Gregory H. Reaman, Michael Robbins, A. Kate Sasser, Nancy Valente, Elena Zamagni - Clinical Cancer Research 2017 被引用: 91

  15. Evidence of Clinical Utility: An Unmet Need in Molecular Diagnostics for Patients with Cancer

    著者: David Parkinson, Robert McCormack, Susan M. Keating, Steven Gutman, Stanley R. Hamilton, Elizabeth Mansfield, Margaret Piper, Patricia A. Deverka, Felix W. Frueh, J. Milburn Jessup, Lisa M. McShane, Sean Tunis, Caroline C. Sigman, Gary J. Kelloff - Clinical Cancer Research 2014 被引用: 91

  16. Progress in Cancer Chemoprevention: Development of Diet-Derived Chemopreventive Agents

    著者: Gary J. Kelloff, James A. Crowell, Vernon E. Steele, Ronald A. Lubet, Winfred A. Malone, Charles W. Boone, Levy Kopelovich, Ernest T. Hawk, Ronald Lieberman, Julia Lawrence, Imran Ali, Jaye L. Viner, Caroline C. Sigman - Journal of Nutrition 2000 被引用: 443

  17. Chemoprevention of colon carcinogenesis by organosulfur compounds.

    著者: B. Seetharami Reddy, Chinthalapally V. Rao, Abraham Rivenson, Gary J. Kelloff - 1993 被引用: 226

  18. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer.

    著者: Toshihiko Kawamori, R Lubet, Vernon E. Steele, Gary J. Kelloff, Robert B. Kaskey, Chinthalapally V. Rao, B. Seetharami Reddy - 1999 被引用: 592

  19. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression

    著者: Michael J. Wargovich, Arnaldo Jimenez, Kathy McKee, Vernon E. Steele, Marco A. De Velasco, Johnnie Woods, Roger E. Price, Kenneth N. Gray, Gary J. Kelloff - Carcinogenesis 2000 被引用: 258

  20. Retinoids in chemoprevention and differentiation therapy

    著者: Laura A. Hansen, Caroline C. Sigman, Fausto Andreola, Sharon A. Ross, Gary J. Kelloff, Luigi M. De Luca - Carcinogenesis 2000 被引用: 243

  21. Strategy and planning for chemopreventive drug development: Clinical development plans II

    著者: Gary J. Kelloff, James A. Crowell, Ernest T. Hawk, Vernon E. Steele, Ronald A. Lubet, Charles W. Boone, Joseph M. Covey, Linda A. Doody, Gilbert S. Omenn, Peter Greenwald, W K Hong, David Parkinson, Donya Bagheri, Gregory T. Baxter, Margaret Blunden, Mary K. Doeltz, Karen Eisenhauer, Karen M. Johnson, Gene Knapp, David G. Longfellow, Winfred F. Malone, Susan Nayfield, Harold E. Seifried, Leah M. Swall, Caroline C. Sigman - Journal of Cellular Biochemistry 1996 被引用: 194

  22. Challenges in Clinical Prostate Cancer: Role of Imaging

    著者: Gary J. Kelloff, Peter L. Choyke, Donald S. Coffey - American Journal of Roentgenology 2009 被引用: 183

  23. New science-based endpoints to accelerate oncology drug development

    著者: Gary J. Kelloff, Caroline C. Sigman - European Journal of Cancer 2005 被引用: 93

  24. Chemoprevention of rat prostate carcinogenesis by early and delayed administration of dehydroepiandrosterone.

    著者: K. V. N. Rao, William D. Johnson, Maarten C. Bosland, Ronald A. Lubet, Vernon E. Steele, Gary J. Kelloff, David L. McCormick - 1999 被引用: 78